| Filed On | Filing |
|---|---|
| 24 Apr 2026 |
Form 4: Grow Brian, Chief Commercial Officer
Received 958 shares by exercise or conversion ($1.19K) |
| 11 Mar 2026 |
Form 4: Leibowitz Arthur S, Director
Bought 5,000 shares ($13.4K) |
| 11 Mar 2026 |
Form 4: Driscoll Michael Joseph, Director
Bought 10,000 shares ($26.7K) |
| 03 Mar 2026 |
Form 4: Cavorsi Robert, Vice President, Strategy
Gave up 700 shares to cover exercise price or tax ($2.25K) |
| 20 Feb 2026 |
Form 4: Freedman Lori, Chief Admin. and Legal Officer
Received 245,905 shares as a grant or award · Gave up 14,267 shares to cover exercise price or tax ($54.8K) · Granted 115,812 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Cavorsi Robert, Vice President, Strategy
Received 110,040 shares as a grant or award · Gave up 5,432 shares to cover exercise price or tax ($20.9K) · Granted 53,452 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Francisco David, Chief Financial Officer
Received 238,914 shares as a grant or award · Gave up 14,541 shares to cover exercise price or tax ($55.8K) · Granted 111,358 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Grow Brian, Chief Commercial Officer
Received 282,705 shares as a grant or award · Gave up 11,768 shares to cover exercise price or tax ($45.2K) · Granted 133,630 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Bilbo Patrick, Chief Operating Officer
Received 259,549 shares as a grant or award · Gave up 16,212 shares to cover exercise price or tax ($62.3K) · Granted 120,267 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Gillheeney Gary S., Director
Received 1,077,593 shares as a grant or award · Gave up 90,398 shares to cover exercise price or tax ($347K) · Granted 507,795 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Driscoll Michael Joseph, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Giacomin Jon L, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Leibowitz Arthur S, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Montecalvo Antonio S., Vice President, Health Policy
Received 51,843 shares as a grant or award · Gave up 3,741 shares to cover exercise price or tax ($14.4K) · Granted 23,162 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Quintero Gilberto, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Duraibabu Prathyusha, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Lustig Garrett, Director
Received 48,828 shares as a grant or award |
| 20 Feb 2026 |
Form 4: Korfin Michele Ilene, Director
Received 48,828 shares as a grant or award |
| 18 Feb 2026 |
Form 4: Francisco David, Chief Financial Officer
Gave up 52,448 shares to cover exercise price or tax ($196K) |
| 18 Feb 2026 |
Form 4: Bilbo Patrick, Chief Operating Officer
Gave up 64,414 shares to cover exercise price or tax ($240K) |
Loading...